Invention Grant
- Patent Title: NRF2 activator
-
Application No.: US16473667Application Date: 2017-12-27
-
Publication No.: US10968181B2Publication Date: 2021-04-06
- Inventor: Brian Stuart Lucas , Edward Yin-Shiang Lin , Andrew George Capacci , Zhili Xin , Istvan Enyedy , TeYu Chen , John H. Jones , Kurt D. van Vloten
- Applicant: BIOGEN MA INC.
- Applicant Address: US MA Cambridge
- Assignee: BIOGEN MA INC.
- Current Assignee: BIOGEN MA INC.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Xin Zhang
- International Application: PCT/US2017/068455 WO 20171227
- International Announcement: WO2018/125880 WO 20180705
- Main IPC: C07D311/76
- IPC: C07D311/76 ; C07D217/04 ; C07D217/08 ; C07D223/16 ; C07D498/14 ; A61K31/352 ; A61K31/47 ; C07D217/20 ; C07D217/22 ; C07D223/14 ; C07D311/74 ; C07D401/04 ; C07D401/06 ; C07D405/04 ; C07D405/06 ; C07D413/06 ; C07D498/04
Abstract:
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.
Information query
